BY DOUGLAS SCHERR M.D.

Dr. Douglas Scherr, MD
Dr. Douglas Scherr, MD

Obesity is becoming an increasing concern with regard to prostate cancer treatment decisions as the number of patients with a Body Mass Index (BMI) of greater than 30 grows. While there hasn’t been conclusive study into the area, it has been generally found that obesity is a negative risk factor for prostate cancer.

...continue reading Obesity as a Factor in Prostate Cancer Treatment Options